文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

细菌性阴道病年轻女性宫颈阴道分泌物增强HIV感染

Cervicovaginal Secretions in Young Women With Bacterial Vaginosis Enhance HIV Infection.
PubMed 文献 · J Infect Dis · 2025-01-01

该研究评估细菌性阴道病(BV)患者甲硝唑治疗前后的宫颈阴道黏膜免疫环境,发现BV患者阴道灌洗液增强HIV感染细胞,而对照组抑制感染;增强作用与菌群失调标志物相关,治疗后短暂降低但未持续。

要点

  • BV患者阴道灌洗液增强HIV感染,对照组则抑制。
  • 增强作用与乳杆菌减少及普雷沃菌等增加相关。
  • 甲硝唑治疗后增强作用仅短暂降低。

核心结论

  • BV患者宫颈阴道分泌物增强HIV感染,提供BV增加HIV风险的潜在机制。

研究设计与样本

  • 临床BV患者19例接受口服或阴道甲硝唑治疗,健康对照13例,在入组及约2、4周后采样评估免疫介质、抗病毒活性和16S rRNA基因测序。

主要发现

  • 入组时BV患者阴道pH、Nugent评分、Shannon多样性指数和阴道菌群状态类型与对照组显著不同(P < .001)。
  • BV患者宫颈阴道灌洗液IL-1α和TNF-α显著高于对照组,IgG较低,治疗后改善。
  • BV患者灌洗液增强HIV感染细胞,对照组抑制,相对于缓冲液均值±SD为138.4%±109.8% vs 30.9%±37.9%(P = .001)。
  • 治疗后HIV增强作用短暂降低但未持续,增强与菌群状态类型和失调标志物相关。

临床怎么用

  • 提示BV的早期诊断和改善治疗可能有助于降低HIV风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bacterial vaginosis (BV) is a major health problem associated with increased HIV risk. To explore underlying mechanisms, we assessed the cervicovaginal mucosal immune environment before and after metronidazole treatment in women with BV and healthy controls. METHODS: Women with BV diagnosed clinically by Amsel criteria were treated with oral or intravaginal metronidazole. Vaginal swabs and cervicovaginal lavage (CVL) were obtained at enrollment and approximately 2 and 4 weeks later for assessment of immune mediators, antiviral activity, and 16-second rRNA gene sequencing. Healthy controls had sampling at enrollment and 4 weeks. RESULTS: Vaginal pH, Nugent score, Shannon diversity index, and vaginal community state types differed significantly at enrollment between women with clinical BV (n = 19) and controls (n = 13, P < .001). BV cases had significantly higher CVL IL-1α and TNF-α but lower IgG at enrollment as compared with controls, which improved following treatment. Similar results were observed if participants with discordant molecular results (n = 3) were excluded. Most notably, CVL from BV cases enhanced, whereas control CVL inhibited, HIV infection of cells relative to buffer (mean ± SD, 138.4% ± 109.8% vs 30.9% ± 37.9%; P = .001). There was a transient reduction in HIV enhancement following treatment, which was not sustained. Enhancement correlated with community state types and markers of dysbiosis. Specifically, decreases in lactobacilli and increases in Prevotella, Dialister micraerophilus, and Peptoniphilus lacrimalis were associated with enhancement. CONCLUSIONS: These findings provide a potential mechanistic link that may contribute to the increased risk of HIV in association with BV, and they highlight the importance of early diagnosis and improved treatments.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Keller MJ, Wang T, Murphy K, et al. Cervicovaginal Secretions in Young Women With Bacterial Vaginosis Enhance HIV Infection. J Infect Dis. 2025. PMID: 40838343. doi:10.1093/infdis/jiaf444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。